Which health-related quality-of-life outcome when planning randomized trials: Disease-specific or generic, or both? A common factor model

Value in Health

Volumn 16, Issue 1, 2013, Pages 185-194

  Ades, A E ^a   Lu, Guobing ^a   Madan, Jason J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

cost effectiveness analysis; disease specific health related quality of life; generic health related quality of life; mapping; measurement error

Indexed keywords

ACCURACY; ARTICLE; CORRELATION COEFFICIENT; COST EFFECTIVENESS ANALYSIS; DISEASE SPECIFIC MEASURE; EFFECT SIZE; INTERMETHOD COMPARISON; MATHEMATICAL MODEL; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PRODUCTIVITY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELIABILITY; SCIENTIST; SCORING SYSTEM; STUDY DESIGN;

COST-BENEFIT ANALYSIS; HUMANS; MODELS, THEORETICAL; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 84872695405     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2012.09.012     Document Type: Article

References (21)

1. J.F. Fries, P. Spitz, G. Kraines, and H. Holman Measurement of patient outcome in arthritis Arthritis Rheum 23 1980 137 145
2. T. Fredriksson, and U. Pettersson Severe psoriasis - oral therapy with a new retinoid Dermatologica 157 1978 238 244
3. M.F. Folstein, S.E. Folstein, and P.R. McHugh Mini-mental state: a practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 1975 189 198
4. A.T. Beck, C.H. Ward, and M. Mendelson An inventory for measuring depression Arch Gen Pyschiatry 4 1961 561 571
5. M. Hamilton A rating scale for depression J Neurol Neurosurg Psychiatry 23 1960 56 62
6. S. Wiebe, G. Guyatt, and B. Weaver Comparative responsiveness of generic and specific quality-of-life instruments J Clin Epidemiol 56 2003 52 60
7. L.M. Friedman, C.D. Furberg, and D.L. DeMets Fundamentals of Clinical Trials 4th ed. 2010 Springer New York
8. J.E. Brazier, Y. Yang, A. Tsuchiya, and D.L. Rowen A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures Eur J Health Econ 11 2010 215 225
9. Brazier JE, Longworth L. NICE DSU Technical Support Document 8: An introduction to the measurement and valuation of health for NICE submissions. Available from: http://www.nicedsu.org.uk/ TSD8%20Introduction%20to%20MVH-final. pdf. [Accessed August 1, 2011].
10. Lu G., Brazier JE, Ades AE. Mapping from disease-specific to generic health-related quality of life scales: A common factor model. Value Health 2012:16;177-84.
11. S.J. Walters Quality of Life Outcomes in Clinical Trials and Health-Care Evaluation: A Practical Guide to Analysis and Interpretation (Statistics in Practice) 2009 Wiley Chichester
12. D. Kessler, G. Lewis, and S. Kaur Therapist-delivered Internet psychotherapy for depression in primary care: a randomised controlled trial Lancet 374 2009 628 634
13. J. Cohen Statistical Power Analysis for the Behavioral Sciences 2nd ed. 1988 Erlbaum Hillsdale, NJ
14. Malottki K., Barton P., Tsourapas A., et al. Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review and economic evaluation. Health Technol Assess 2011;15:1-278.
15. C. Ekdahl, K. Eberhardt, S.I. Andersson, and B. Svensson Assessing disability in patients with rheumatoid arthritis: use of a Swedish version of the Stanford Health Assessment Questionnaire Scand J Rheumatol 17 1988 263 271
16. N.P. Hurst, P. Kind, and D. Ruta Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQOL (EQ-5D) Br J Rheumatol 36 1997 551 559
17. C.A. Marra, A.A. Rashidi, and D. Guh Are indirect utility measures reliable and responsiveness in rheumatoid arthritis patients? Qual Life Res 14 2005 1333 1344
18. K. Malottki, P. Barton, and A. Tsourapas Adalimumab, Etanercept, Infliximab, Rituximab and Abatacept for the Treatment of Rheumatoid Arthritis after the Failure of a TNF Inhibitor: A Systematic Review and Economic Evaluation 2009 National Institute for Health and Clinical Excellence London
19. P.J. Mease, D.D. Gladman, and C.T. Ritchlin Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial Arthritis Rheum 52 2005 3279 3289
20. R. Uher, A. Farmer, and W. Maier Measuring depression: comparison and integration of three scales in the GENDEP study Psychol Med 38 2008 289 300
21. R.A. Johnson, and D.W. Wichern Applied Multivariate Statistical Analysis 6th ed. 2007 Pearson Education New York